Table 2.
Variations of the laboratory analyses and vital signs between the screening and the final visit (ISOFEN1)
| Screening visit | Final visit | |
|---|---|---|
| Creatinine (mg/dL) | 0.88±0.09 | 0.87±0.10 |
| Urea (mg/dL) | 32±6.75 | 34±5.08 |
| ALT (U/L) | 23±8.09 | 23±9.11 |
| ALP (U/L) | 61±14.3 | 61±13.55 |
| GGT (U/L) | 22±12.79 | 25±13.73 |
| WBC (103/μL) | 6.18±1.77 | 6.41±1.30 |
| RBC (106/μL) | 5.04±0.44 | 5.47±1.66 |
| Platelet (103/μL) | 200±46.91 | 215±62.99 |
| Systolic blood pressure (mmHg) | 126±6 | 109±3.59 |
| Diastolic blood pressure (mmHg) | 68±11 | 67±6.34 |
| Heart rate (bpm) | 82±2 | 67±7.78 |
Note: Values are expressed as mean ± standard deviation.
Abbreviations: ALT, alanine aminotransferase; ALP, alkaline phosphatase; GGT, gamma glutamyl transpeptidase; WBC, white blood cells; RBC, red blood cells; n, number.